AZN

+4.2%🔴 Potential overreaction

AstraZeneca PLC · Healthcare

$162.37Vol 1.76M · 0.8× normalMkt cap +$10.15Blive · 2026-10-14 ET

What happened

Move

+4.2%

Price

$162.37

Volume

1.76M

0.8× normal

Market cap

$251.81B

+$10.15B today

Why it moved

No clear catalyst identified

No reliable news, earnings or analyst driver was found for this move. A move this size without an obvious driver is most likely flow/positioning-driven rather than a fundamentals story.

Additional context: Citi's $4.4bn peak sales estimate for efzimfotase alfa and FDA NDA submission for the lung cancer combo.

Verdict — was the move justified?

🔴 Potential overreaction

A 3.4σ move well beyond the sector with no identified fundamental or news driver — the reaction appears larger than currently visible evidence justifies. Likely flow/positioning-driven.

How unusual is this move

σ score

3.4σ

vs own 20d volatility

Percentile

98th

of 1277 daily moves

Avg daily move

±1.1%

own 5y average

vs sector

+2.9%

beyond sector median

Today’s move is among the largest 2% of AZN’s daily moves over the last 5 years — while the sector moved +1.3% and the market -0.9%.

What happened after similar moves

45 similar up moves in AZN’s 5-year history:

After 5 days

+0.8%

64% higher

After 20 days

+1.5%

64% higher

Median of same-direction moves within ±35% magnitude band. Past patterns don’t predict outcomes — context, not signal.

Fundamental context

V 64G 70P 72H 61Q 85

Insider activity (90d): net buying $3.2K

Valuation context

P/E (TTM)

23.6

5y median 40.9

P/E percentile

34%

vs own 5y history

FCF yield

0.0%

Valuation sits near the middle of its own historical range (34th percentile).

Full fundamental analysis on PreMarketPrice

Pillar scores, financial statements, valuation history, news & more for AZN

→